(TheNewswire)
The PrototypePrinting Marks a Major Milestone in the Production LaunchTimeline
VANCOUVER, British Columbia – TheNewswire - September 21, 2023 - BYNDCannasoft Enterprises Inc. (Nasdaq: BCAN ) ( CSE :BYND )(“ BYND Cannasoft ” or the “ Company ”), proudly announced today thatafter a year of intensive development of the EZ-G Device, the fulldesign of the product is completed, and that the company has sent thefirst prototype for printing. The Company previously shared keyupdates in August relating to the production timeline and the printing of the EZ-GDevice prototype marks another milestone achieved in this roadmap.
The prototype is the first of its kind in thiscategory that combines technical elements of hardware such asperistaltic pumps, a heart rate sensor, pressure sensor, and EC sensorthat work together to learn about your body as well as a patentpending system that regulates the flow of low-concentration CBD oilsfrom capsules through the device to the area needed. The device willcombine AI algorithms and machine learning processes from thesesensors to collect data on the user’s needs and preferences tocreate a personalized experience. Data collected by the device'ssensors can be uploaded to the cloud, where user preferences will bestored. We believe that these personalized results will make theproduct standout in the female community for both its potential andbenefits.
Image depicting the EZ-G Device and AI-poweredapplication.
“We are very proud of the fact that after a full yearof our continuous efforts we are at the point where our idea hasbecome a real prototype,” said Yftah Ben Yaackov, CEO and Directorof BYND Cannasoft. “ This milestone is veryimportant to us, and we hope to stay on track to the market launch inthe second quarter of 2024. We believe that our device is unique anddesigned with the modern woman in mind to equip them with acutting-edge device that offers a truly unique and personalizedexperience. We hope that its introduction to the women’s healthmarket will bring real positive change to the industry.”
Mr. Ben Yaackov continued, "As we continue intothe last few months of the year and collaborate with esteemed partnersand institutions, we remain dedicated to our mission and are excitedto share more progress announcements very soon.”
About BYND Cannasoft EnterprisesInc.
BYND Cannasoft Enterprises is an Israeli-basedintegrated software and cannabis company. BYND Cannasoft owns andmarkets "Benefit CRM," a proprietary customer relationshipmanagement (CRM) software product enabling small and medium?sizedbusinesses to optimize their day?to?day business activities suchas sales management, personnel management, marketing, call centeractivities, and asset management. Building on our 20 years ofexperience in CRM software, BYND Cannasoft is developing an innovativenew CRM platform to serve the needs of the medical cannabis industryby making it a more organized, accessible, and price-transparentmarket. The Cannabis CRM System will include a Job Management(BENEFIT) and a module system (CANNASOFT) for managing farms andgreenhouses with varied crops.
BYND Cannasoft owns the patent-pending intellectualproperty for the EZ-G device. This therapeutic device uses proprietarysoftware to regulate the flow of low concentrations of CBD oil, hempseed oil, and other natural oils into the soft tissues of the femalereproductive system to potentially treat a wide variety of women'shealth issues. The EZ-G device includes technological advancements asa sex toy with a more realistic experience and the prototype utilizessensors to determine what enhances the users' pleasure. The user cancontrol the device through a Bluetooth app installed on a smartphoneor other portable device. The data will be transmitted and receivedfrom the device to and from the secure cloud using artificialintelligence (AI). The data is combined with other antonymic userpreferences to improve its operation by increasing sexualsatisfaction.
For Further Information, please refer to informationavailable on the Company’s website: www.cannasoft-crm.com, theCSE’s website:www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-incand on SEDAR+: www.sedarplus.ca .
Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e?mail: ir@cannasoft-crm.com
For Media and Investor Relations, pleasecontact:
TraDigital IR
Tel: (212) 389-9782 x.108
Email: colette@tradigitalir.com
Cautionary Note RegardingForward-Looking Statements
This press release includes certain statements that maybe deemed “forward-looking statements”. All statements in thisrelease, other than statements of historical facts, that addressfuture events or developments that the Company expects, areforward-looking statements. Although the Company believes the expectations expressed in such forward-looking statementsare based on reasonable assumptions, such statements are notguarantees of future performance, and actual events or developmentsmay differ materially from those in forward-looking statements. Suchforward-looking statements necessarily involve known and unknown risksand uncertainties, which may cause the Company’s actual performanceand financial results in future periods to differ materially from anyprojections of future performance or results expressed or implied bysuch forward-looking statements. Such statements reflect the Company'scurrent views with respect to future events and are subject to suchrisks and uncertainties. Many factors could cause actual results todiffer materially from the statements made, including future financialperformance, unanticipated regulatory requests and delays, finalpatents approval, and those factors discussed in filings made by thecompany with the Canadian securities regulatory authorities, including(without limitation) in the company's management's discussion andanalysis for the year ended December 31, 2022 and annual informationform dated March 31, 2023, which are available under the company'sprofile at www.sedar.com, and in the Company’s Annual Report on Form20-F for the year then ended that was filed with the U.S. Securitiesand Exchange Commission on April 27, 2023. Should one or more of thesefactors occur, or should assumptions underlying the forward-lookingstatements prove incorrect, actual results may vary materially fromthose described herein as intended, planned, anticipated, or expected.We do not intend and do not assume any obligation to update theseforward?looking statements, except as required by law. Any suchforward-looking statements represent management's estimates as of thedate of this press release. While we may elect to update suchforward-looking statements at some point in the future, we disclaimany obligation to do so, even if subsequent events cause our views tochange. Shareholders are cautioned not to put undue reliance on suchforward?looking statements.
Copyright (c) 2023 TheNewswire - All rights reserved.